15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults : A Systematic Review and Meta-analysis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          Is there an association between e-cigarette use and cigarette smoking among adolescents and young adults?

          Finding

          A systematic review and meta-analysis showed strong and consistent evidence of an association between initial e-cigarette use and subsequent cigarette smoking initiation, as well as between past 30-day e-cigarette use and subsequent past 30-day cigarette smoking.

          Meaning

          To minimize the potential public health harm from e-cigarette use, the US Food and Drug Administration, as well as state and local agencies, will need to engage in effective regulatory actions to discourage youths’ use of e-cigarettes and prevent the transition from e-cigarettes to other combustible tobacco products.

          Abstract

          Importance

          The public health implications of e-cigarettes depend, in part, on whether e-cigarette use affects the risk of cigarette smoking.

          Objective

          To perform a systematic review and meta-analysis of longitudinal studies that assessed initial use of e-cigarettes and subsequent cigarette smoking.

          Data Sources

          PubMed, EMBASE, Cochrane Library, Web of Science, the 2016 Society for Research on Nicotine and Tobacco 22nd Annual Meeting abstracts, the 2016 Society of Behavioral Medicine 37th Annual Meeting & Scientific Sessions abstracts, and the 2016 National Institutes of Health Tobacco Regulatory Science Program Conference were searched between February 7 and February 17, 2017. The search included indexed terms and text words to capture concepts associated with e-cigarettes and traditional cigarettes in articles published from database inception to the date of the search.

          Study Selection

          Longitudinal studies reporting odds ratios for cigarette smoking initiation associated with ever use of e-cigarettes or past 30-day cigarette smoking associated with past 30-day e-cigarette use. Searches yielded 6959 unique studies, of which 9 met inclusion criteria (comprising 17 389 adolescents and young adults).

          Data Extraction and Synthesis

          Study quality and risk of bias were assessed using the Newcastle-Ottawa Scale and the Risk of Bias in Non-randomized Studies of Interventions tool, respectively. Data and estimates were pooled using random-effects meta-analysis.

          Main Outcomes and Measures

          Among baseline never cigarette smokers, cigarette smoking initiation between baseline and follow-up. Among baseline non–past 30-day cigarette smokers who were past 30-day e-cigarette users, past 30-day cigarette smoking at follow-up.

          Results

          Among 17 389 adolescents and young adults, the ages ranged between 14 and 30 years at baseline, and 56.0% were female. The pooled probabilities of cigarette smoking initiation were 23.2% for baseline ever e-cigarette users and 7.2% for baseline never e-cigarette users. The pooled probabilities of past 30-day cigarette smoking at follow-up were 21.5% for baseline past 30-day e-cigarette users and 4.6% for baseline non–past 30-day e-cigarette users. Adjusting for known demographic, psychosocial, and behavioral risk factors for cigarette smoking, the pooled odds ratio for subsequent cigarette smoking initiation was 3.50 (95% CI, 2.38-5.16) for ever vs never e-cigarette users, and the pooled odds ratio for past 30-day cigarette smoking at follow-up was 4.28 (95% CI, 2.52-7.27) for past 30-day e-cigarette vs non–past 30-day e-cigarette users at baseline. A moderate level of heterogeneity was observed among studies ( I 2  = 56%).

          Conclusions and Relevance

          e-Cigarette use was associated with greater risk for subsequent cigarette smoking initiation and past 30-day cigarette smoking. Strong e-cigarette regulation could potentially curb use among youth and possibly limit the future population-level burden of cigarette smoking.

          Abstract

          This systematic review and meta-analysis assesses initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults.

          Related collections

          Author and article information

          Journal
          JAMA Pediatr
          JAMA Pediatr
          JAMA Pediatr
          JAMA Pediatrics
          American Medical Association
          2168-6203
          2168-6211
          26 June 2017
          August 2017
          13 November 2017
          26 June 2018
          : 171
          : 8
          : 788-797
          Affiliations
          [1 ]Dartmouth-Hitchcock Norris Cotton Cancer Center, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire
          [2 ]The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire
          [3 ]Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles
          [4 ]University of Hawaii Cancer Center, Honolulu
          [5 ]Annenberg School for Communication, University of Pennsylvania, Philadelphia
          [6 ]currently a medical student at Warren Alpert Medical School of Brown University, Providence, Rhode Island
          [7 ]Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
          [8 ]Oregon Research Institute, Eugene
          [9 ]Institute for Social Research, University of Michigan, Ann Arbor
          [10 ]Department of Psychology, Virginia Commonwealth University, Richmond
          Author notes
          Article Information
          Accepted for Publication: March 30, 2017.
          Corresponding Author: Samir Soneji, PhD, The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth Geisel School of Medicine, One Medical Center Drive, Lebanon, NH 03756 ( samir.soneji@ 123456dartmouth.edu ).
          Correction: This article was corrected on November 13, 2017, to fix errors in data input in Results, Figure 2, and Table 2.
          Published Online: June 26, 2017. doi:10.1001/jamapediatrics.2017.1488
          Author Contributions: Dr Soneji had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
          Study concept and design: Soneji, Barrington-Trimis, Wills, Leventhal, Unger, Gibson, Yang, Primack, Andrews, Hornik, Sargent.
          Acquisition, analysis, or interpretation of data: All authors.
          Drafting of the manuscript: Soneji, Barrington-Trimis, Wills, Leventhal, Unger, Gibson, Yang, Primack, Sargent.
          Critical revision of the manuscript for important intellectual content: All authors.
          Statistical analysis: Soneji, Barrington-Trimis, Unger, Gibson, Yang, Dang.
          Obtained funding: Soneji, Barrington-Trimis, Wills, Unger, Gibson, Primack, Andrews, Spindle, Eissenberg, Hornik.
          Administrative, technical, or material support: Soneji, Sargent.
          Study supervision: Soneji, Wills, Sargent.
          Conflict of Interest Disclosures: Dr Eissenberg reported being a paid consultant in litigation against the tobacco industry and reported being named on a patent application for a device that measures the puffing behavior of e-cigarette users. No other disclosures were reported.
          Funding/Support: This study was supported by grants R21-CA197912 (Dr Soneji), R01-CA077026 (Dr Sargent), R01-CA140150 (Dr Primack), R21-CA185767 (Dr Primack), and R01-CA153154 and P30-CA071789-16S2 (Dr Wills) from the National Cancer Institute (NCI) at the National Institutes of Health (NIH); grants P50-CA180905 (Drs Barrington-Trimis and Unger) and P50-CA179546 (Drs Gibson and Hornik) from the NCI and the US Food and Drug Administration Center for Tobacco Products; and grants P50-DA036105 (Mr Spindle and Dr Eissenberg), R01-DA033296 (Dr Leventhal), R01-DA10767 (Dr Andrews), and R01-DA016310 (Dr Unger) from the National Institute on Drug Abuse at the NIH.
          Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
          Disclaimer: The content is solely the responsibility of the authors and does not necessarily represent the views of the National Institutes of Health or the US Food and Drug Administration.
          Additional Contributions: Sharon Black, MSLIS (University of Pennsylvania), Heather Blunt, MSLIS (Dartmouth College), and Heather Johnson, MLIS (Dartmouth College) assisted in conducting the literature search. None received compensation.
          Article
          PMC5656237 PMC5656237 5656237 poi170040
          10.1001/jamapediatrics.2017.1488
          5656237
          28654986
          36c0ba26-74fc-47c9-9bcb-c632c4fbed8d
          Copyright 2017 American Medical Association. All Rights Reserved.
          History
          : 28 February 2017
          : 23 March 2017
          : 30 March 2017
          Categories
          Research
          Research
          Original Investigation
          Featured
          Online First

          Comments

          Comment on this article